Diagnostic Accuracy of Predictive Models in Prostate Cancer: A Systematic Review and Meta-Analysis.
Journal
Prostate cancer
ISSN: 2090-3111
Titre abrégé: Prostate Cancer
Pays: Egypt
ID NLM: 101567074
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
01
2022
revised:
17
05
2022
accepted:
20
05
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
21
6
2022
Statut:
epublish
Résumé
Accurate diagnosis of prostate cancer (PCa) has a fundamental role in clinical and patient care. Recent advances in diagnostic testing and marker lead to standardized interpretation and increased prescription by clinicians to improve the detection of clinically significant PCa and select patients who strictly require targeted biopsies. In this study, we present a systematic review of the overall diagnostic accuracy of each testing panel regarding the panel details. In this meta-analysis, using a structured search, Web of Science and PubMed databases were searched up to 23 September 2019 with no restrictions and filters. The study's outcome was the AUC and 95% confidence interval of prediction models. This index was reported as an overall and based on the WHO region and models with/without MRI. The thirteen final articles included 25,691 people. The overall AUC and 95% CI in thirteen studies were 0.78 and 95% CI: 0.73-0.82. The weighted average AUC in the countries of the Americas region was 0.73 (95% CI: 0.70-0.75), and in European countries, it was 0.80 (95% CI: 0.72-0.88). In four studies with MRI, the average weighted AUC was 0.88 (95% CI: 0.86-0.90), while in other articles where MRI was not a parameter in the diagnostic model, the mean AUC was 0.73 (95% CI: 0.70-0.76). The present study's findings showed that MRI significantly improved the detection accuracy of prostate cancer and had the highest discrimination to distinguish candidates for biopsy.
Identifiants
pubmed: 35719243
doi: 10.1155/2022/1742789
pmc: PMC9200600
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1742789Informations de copyright
Copyright © 2022 Mohammad Saatchi et al.
Déclaration de conflit d'intérêts
All authors claim that there are no potential conflicts of interest.
Références
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Eur Urol. 2015 Dec;68(6):1045-53
pubmed: 25656808
J Clin Oncol. 2011 Aug 1;29(22):2959-64
pubmed: 21690464
Biom J. 2012 Jan;54(1):127-42
pubmed: 22095849
Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):255-61
pubmed: 21148123
Eur Urol. 2017 Jul;72(1):45-51
pubmed: 28162815
Epidemiol Rev. 2001;23(1):152-8
pubmed: 11588841
BJU Int. 2016 Mar;117(3):409-17
pubmed: 25847734
Prostate Cancer Prostatic Dis. 2019 Dec;22(4):609-616
pubmed: 30988407
Prostate Cancer Prostatic Dis. 2022 Jan 24;:
pubmed: 35067674
BJU Int. 2012 Apr;109 Suppl 3:57-63
pubmed: 22458496
BJU Int. 2017 Dec;120(6):774-781
pubmed: 28207981
Prostate. 2000 Feb 15;42(3):181-5
pubmed: 10639188
Eur Urol. 2014 Sep;66(3):430-6
pubmed: 24377803
Lancet. 2014 Dec 6;384(9959):2027-35
pubmed: 25108889
AJR Am J Roentgenol. 2013 Nov;201(5):1041-8
pubmed: 24147475
Pharmgenomics Pers Med. 2018 May 16;11:83-94
pubmed: 29844697
J Magn Reson Imaging. 2018 May;47(5):1227-1236
pubmed: 28872226
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):596-611
pubmed: 33219368
World J Urol. 2012 Apr;30(2):149-55
pubmed: 22203238
Nat Rev Urol. 2019 May;16(5):302-317
pubmed: 30962568
JAMA Oncol. 2018 May 1;4(5):678-685
pubmed: 29470570
N Engl J Med. 2012 Aug 16;367(7):595-605
pubmed: 22894572
J Urol. 2016 Dec;196(6):1613-1618
pubmed: 27320841
Prostate Cancer. 2019 Mar 03;2019:6932572
pubmed: 30941221
BJU Int. 2007 Sep;100(3):506-8
pubmed: 17559563
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
Mol Genet Genomic Med. 2019 Sep;7(9):e873
pubmed: 31321921
Asian J Urol. 2019 Apr;6(2):129-136
pubmed: 31061798
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720
pubmed: 23440794
Cancers (Basel). 2020 Jan 09;12(1):
pubmed: 31936460
JCO Clin Cancer Inform. 2018 Dec;2:1-10
pubmed: 30652591
Radiology. 2009 Jan;250(1):273-80
pubmed: 19092098
Clin Cancer Res. 2010 Jun 15;16(12):3232-9
pubmed: 20400522
NMR Biomed. 2016 Mar;29(3):232-8
pubmed: 26730884
Turk J Urol. 2020 Jan 1;46(1):50-56
pubmed: 31905124
J Urol. 2008 Feb;179(2):501-3
pubmed: 18076916
J Nucl Med. 2022 Jun;63(6):847-854
pubmed: 34649942